McDermott Will & Schulte advises Ardian Growth on its exit from the Proteor Group | McDermott Skip to main content

McDermott Will & Schulte advises Ardian Growth on its exit from the Proteor Group

McDermott Will & Schulte advises Ardian Growth on its exit from the Proteor Group

Overview


McDermott Will & Schulte advised Ardian Growth on its exit from the Proteor Group, a recognised player in the orthopaedics market.

Eurazeo, through its Nov Santé Actions Non Cotées fund, Crédit Mutuel Equity and Bpifrance are acquiring a stake in the family-owned group, alongside BNP Paribas Développement, which is reinvesting in the transaction.

The McDermott Will & Schulte team comprised:

About Us


Leading organizations turn to global law firm McDermott Will & Schulte for a better way to address legal challenges, connect with those at the forefront, and drive stronger outcomes. Working across more than 20 offices globally, our 1,750+ lawyers act on data-driven insights, deep relationships, and unmatched industry experience to deliver on our commitment of Always Better.